Open AccessOridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Author(s) -
Xuguang Li,
Weirun Chen,
Kaihang Liu,
Sheng Zhang,
Renqiang Yang,
Kairui Liu,
Dateng Li,
Youxing Huang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s310256
Subject(s) - sorafenib , hepatocellular carcinoma , cancer research , protein kinase b , medicine , pharmacology , oncology , signal transduction , biology , microbiology and biotechnology